Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk.

Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, Gastaldelli A; ACT NOW Study..

Diabetes Care. 2013 Nov;36(11):3607-12. doi: 10.2337/dc13-0520. Epub 2013 Sep 23.

2.

Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.

Henninger J, Hammarstedt A, Rawshani A, Eliasson B.

BMC Endocr Disord. 2015 Sep 25;15:51. doi: 10.1186/s12902-015-0048-8.

3.

Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.

Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo G, Leonetti F, Bonadonna RC, Del Prato S; GENFIEV Investigators..

J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28.

PMID:
23539736
4.

Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.

Cubeddu LX, Hoffmann IS.

Metab Syndr Relat Disord. 2012 Oct;10(5):344-50. Epub 2012 Jul 17.

PMID:
22803772
5.

Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.

Tripathy D, Clement SC, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA.

Diabetes Care. 2014 Jun;37(6):1706-11. doi: 10.2337/dc13-1745. Epub 2014 Apr 4.

6.
8.

Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy.

Brufani C, Ciampalini P, Grossi A, Fiori R, Fintini D, Tozzi A, Cappa M, Barbetti F.

Pediatr Diabetes. 2010 Feb;11(1):47-54. doi: 10.1111/j.1399-5448.2009.00527.x. Epub 2009 Apr 30.

PMID:
19460122
9.

Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group..

Diabetes. 2002 Jul;51(7):2170-8.

10.

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study..

Diabetes Care. 2003 Mar;26(3):868-74.

PMID:
12610051
11.

Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates.

Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD; ACT NOW Study..

Diabetes. 2013 Nov;62(11):3920-6. doi: 10.2337/db13-0265. Epub 2013 Jul 17.

12.

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA.

Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.

PMID:
21553243
13.

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.

DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group..

Diabetologia. 2010 Mar;53(3):435-45. doi: 10.1007/s00125-009-1614-2. Epub 2009 Dec 10.

PMID:
20012012
14.

Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.

Kim YA, Ku EJ, Khang AR, Hong ES, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S.

Diabetes Res Clin Pract. 2014 Nov;106(2):351-9. doi: 10.1016/j.diabres.2014.08.014. Epub 2014 Sep 3.

PMID:
25245975
15.

Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

Diabetes Care. 1998 Jan;21(1):76-9.

PMID:
9538973
16.

Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum.

Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, Retnakaran R.

Diabetes Care. 2014 Dec;37(12):3262-9. doi: 10.2337/dc14-1529. Epub 2014 Sep 17.

PMID:
25231898
17.

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.

Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K.

Diabetologia. 2008 May;51(5):853-61. doi: 10.1007/s00125-008-0951-x. Epub 2008 Mar 4.

PMID:
18317726
18.

[Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].

Xiao J, Tian H, Li CL, Zhong WW, Sun BR, Li YP, Fang FS, Han XF, Liu YQ, Cheng XL.

Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):299-303. Chinese.

PMID:
22781951
19.

A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.

Tripathy D, Cobb JE, Gall W, Adam KP, George T, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Reaven PD, Musi N, Ferrannini E, DeFronzo RA.

J Clin Endocrinol Metab. 2015 May;100(5):1855-62. doi: 10.1210/jc.2014-3824. Epub 2015 Jan 20.

Supplemental Content

Support Center